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Abstract A MAP kinase homologue, termed the reactivating 
kinase (RK), lies in a signalling pathway which mediates cellular 
responses to stress. Here we demonstrate that the stress-induced 
activation of the RK in human KB cells is accompanied by the 
phosphorylation of Thr-180 and Tyr-182, and that the phospho- 
rylation of both residues is required for the activation of this 
enzyme. 
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1. Introduction 
The p42 and p44 isoforms of mitogen-activated protein 
(MAP) kinase (p42/p44 MAPK) are central components of a 
signalling pathway which is activated by mitogens and growth 
factors and whose sustained activation isnot only required, but 
sufficient to trigger the proliferation or differentiation f many 
cells (reviewed in [1]). Recently a bomologue of p42/p44 
MAPK, termed the reactivating kinase (RK), was identified in 
mammalian cells which is activated in response to cellular 
stresses [2], bacterial endotoxin (LPS) [3] and the cytokine inter- 
leukin-I (IL-1) [4]. One of the downstream targets of the RK 
is MAP kinase-activated protein (MAPKAP) kinase-2 [2,5,6] 
which phosphorylates heat-shock protein HSP27 [5,6]. There 
is evidence that HSP27 phosphorylation promotes the polymer- 
isation of actin, and so counteracts he disruptive ffects of 
stress on actin microfilament s ructure, thereby aiding cell sur- 
vival [7]. 
The RK is inhibited specifically by a novel class of pyridinyl 
imidazoles, termed CSAIDs, which inhibit the activation of 
MAPKAP kinase-2 and the phosphorylation f HSP27 in vivo 
in response to cellular stresses, LPS and IL-1 [6]. CSAIDs were 
originally developed as inhibitors of the LPS-induced synthesis 
of IL-I and tumour necrosis factor (TNF) in monocytes [8], 
implicating proteins 'downstream' of the RK in the synthesis 
of these cytokines. For these reasons CSAIDs may be effi- 
caceous in the treatment of inflammatory diseases, such as 
rheumatoid arthritis. 
*Corresponding author. Fax: (44) (383) 223 778. 
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The p42/p44 MAPKs are activated by phosphorylation f a 
threonine and a tyrosine residue located in a TEY sequence 
(Thr-183 and Tyr-185 of p42 MAPK) just N-terminal to the 
APE motif found between subdomains VII and VIII of nearly 
all protein kinases [9]. The activation of p42/p44 MAPKs is 
catalysed by the "dual specificity" enzyme MAP kinase kinase 
(MAPKK) which phosphorylates both residues [10], while inac- 
tivation is catalysed by protein phosphatase 2A (PP2A) which 
dephosphorylates Thr-183 specifically [9,11], by protein tyro- 
sine phosphatases which dephosphorylate Tyr-185 [9,11], and 
by CLI00, a 'dual specificity' enzyme which dephosphorylates 
both residues [12,13]. 
The RK is most similar to HOGI, an S. cerevisiae MAP 
kinase homologuc that lies in a signalling pathway which re- 
stores the osmotic gradient across the yeast cell membrane in
response to high external osmolarity [14]. The RK and HOGI 
both contain the sequence TGY (residues 180 182 in mammal- 
ian RK) located in the equivalent position to the TEY sequence 
of p42 and p44 MAPKs [2,3]. The RK, like p42/44 MAPKs is 
inactivated in vitro by PP2A, protein tyrosine phosphatase 
(PTP)-IB or CLI00 [2]. However, whether Thr-180 and Tyr- 
182 are the key phosphorylation sites in vivo, or whether acti- 
vation results from the phosphorylation of alternative/addi- 
tional residues is unknown. In this paper we identify the sites 
on the RK whose phosphorylation is induced by cellular stress 
in human KB cells and elucidate their role in the activation and 
inactivation of this enzyme. 
2. Materials and methods 
2.1. Materials 
Radiochemicals were purchased from Amersham International 
(Amersham, U K), protein A-Sepharose and reduced Triton X- 100 from 
Sigma (Poole, UK), glutathione-Sepharose and protein G-Sepharose 
from Pharmacia (Milton Keynes, UK) and sequence grade modified 
trypsin from Promega (Southampton, UK). Antibodies against he 
C-terminal 14 residues of XMpk2, a Xenopus RK homologue, which 
immunoprecipitates RK from rat PCI2 cells (hereafter termed anti-RK 
antibodies) were raised in rabbits [2]. The catalytic subunit of PP2A was 
purified from bovine heart as for rabbit muscle PP2A [15] and provided 
by Dr. R.W. MacKintosh at Dundee. Bacterially expressed PTP-1B 
and GST-MAPKAP kinase-2 were gilts from Dr. D. Barford (Univer- 
sity of Oxford, UK) and Dr. R. Ben-Levi and Professor C.J. Marshall 
(Institute of Cancer Research, London), respectwely. 
2.2. Preparation q/a constitutively activated mutant o/Xenopus MEK2 
XMEK2 eDNA, a generous gill from Dr. B. Errede (University o1" 
North Carolina, USA) was amplified by PCR with oligonucleotides 
designed tocreate an NeoI site at the first ATG cndon and an Xhol site 
in front of the TGA stop codon. The PCR product was digested with 
Neol and XhoI, and ligated into the Ncol XhoI site of the vector 
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pET21-GST [2]. The GST-XMEK2(E286, E290) mutant was prepared 
essentially as in [16], using as a template the plasmid pET21-GST- 
XMEK2 and two verlapping oligonucleotides designed to change both 
codons 286 (TCC) and 290 (ACC) to GAG. The expression plasmids 
were transformed into E. coli BL21(DE3) and after induction with 0.5 
mM IPTG for 5 h at 20°C, the GST-XMEK2 proteins were purified 
by affinity chromatography on glutathione-Sepharose. 
2.3. Expression of MalEJusion proteins c~JXenopus Mpkl and Mpk2 
The XMpk2 cDNA [2] was subcloned into the Xnml BamH1 site of 
the vector pMAL-c2 (New England Biolabs, MA, USA) and the expres- 
sion plasmid for MalE-XMpkl was prepared as described [2]. The 
sequences of the MalE fusion proteins after the Factor Xa cleavage site 
(IEGR) are ISEFGS followed by amino acids 4-361 of XMpkl and ST 
followed by amino acids 4-361 of XMpk2. The plasmids were trans- 
formed into E. coli TG-I and after induction with 0.2 mM IPTG tk~r 
6 h at 20°C, the MalE-XMpkl and MalE-XMpk2 proteins were puri- 
fied by affinity chromatography onamylose beads as recommended by
the supplier. 
2.4. Pbo~phorylation a d dephosphol3'lation f the RK in vitro 
4 /,tg GST-XMEK2-(E286, E290) and 20/tg MalE-XMpk2 were 
incubated for up to 16 h at 30°C in 0.1 ml of 50 mM Tris-HCl, pH 7.5, 
10 mM magnesium-acetate, 1 mM DTT, 0.1/IM okadaic acid, 0.2 mM 
sodium orthovanadate (buffer A) and 0.1 mM ATP (60/,tCi [y-3-'P]ATP) 
and the reaction mixture was passed through a 5 ml column of Se- 
phadex G-50 Superfine quilibrated in 50 mM Tris-HCl, pH 7.0, 0.1 
mM EDTA, 0.03% (w/v) Brij 35 and 0.1% 2-mercaptoethanol t  re- 
move ATE Dephosphorylation was then carried out for 30 min at 30 ° C 
with 2.5/lg/ml PP2A or 50/lg/ml PTP-1B. In measuring the phospho- 
rylation stoichiometry, the molecular mass of MalE-XMpk2 was taken 
as 84 kDa and protein was estimated by the method of Bradford. 
2.5. Labelling of KB cells in vivo 
KB cells were cultured in 6 cm dishes in a 95% air/5% CO, atmos- 
phere as described [6]. When the cells had reached confluence, ach dish 
was incubated for 5 7 h in 3 ml of phosphate-free DMEM medium 
(ICN, Oxon, UK) supplemented with 10% foetal calf serum (dialysed 
against 20 mM HEPES, pH 7.5, to remove phosphate) in the presence 
of I 2.5 mCi/ml carrier-free [32p]orthophosphate. Thecells were stimu- 
lated for 15 min with 0.5 mM sodium arsenite, lysed in 0.4 ml of 20 mM 
Tris-acetate, pH 7.0, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 1% 
(w/v) Triton X-100, 10 mM sodium fl-glycerophosphate, 50 mM so- 
dium fluoride, 5 mM sodium pyrophosphate, 1 mM sodium orthovana- 
date, 0.1% (v/v) 2-mercaptoethanol, 0.2 mM phenylmethylsulphonyl 
fluoride (termed lysis buffer), centrifuged for 10 min at 13,000 × g (4 ° C) 
and the supernatant ( ermed KB cell extract) removed and used in the 
immunoprecipitation experiments described below. 
2.6. lmmunoprecipitation oJ' the RK j~'om KB cell lysates 
An aliquot of anti-RK antiserum (25/ll) was incubated for 30 rain 
at 4°C on a shaker with 10,ul protein A-Sepharose, and after washing 
the antibody-protein A-Sepharose conjugate three times with phos- 
phate-buffered saline, KB cell extract from one dish of cells was added. 
After incubation for 1 h at 4°C on a shaker, the antibody-antigen- 
protein A-Sepharose was washed three times with lysis buffer contain- 
ing 0.5 M NaCI and once with lysis buffer alone. The supernatant was 
removed, and the antibody-antigen complex resuspended in 10/tl 1% 
SDS, heated for 2 min at 100°C and subjected to electrophoresis on a 
12.5% polyacrylamide gel. 
2.7. Digestion of the RK with trypsin 
The band corresponding to in vivo phosphorylated RK was excised 
from the polyacrylamide gel, and the gel piece homogenised in 5 vols. 
of 25 mM N-ethylmorpholine-HC1, pH 7.7, containing 0.1% (w/v) SDS 
and 0.5% (v/v) 2-mercaptoethanol. The suspension was incubated for 
12 h at 37°C on a shaker, then centrifuged for 5 min at 13,000 x g. The 
supernatant (containing 60~80% of the 32p radioactivity in the gel slice) 
was removed, 2/zl of 10 mg/ml bovine serum albumin (BSA) added and 
0.2 vols. of 100% (w/v) trichloroacetic a id (TCA) added. After centrif- 
ugation for 2 min at 13,000 x g, the TCA pellet was washed 3times with 
20% TCA, 3 times with ice-cold acetone, dried and incubated for 1 h 
at 4°C with 0.1 ml of freshly prepared performic acid. After dilution 
to 0.5 ml with water and lyophilisation, 10 ~'1 of 1% reduced Triton 
A 
GST-XMEK2 wt EE wt EF 
MalE-XMpk2 + + 
MalE-XMpkl + + 
- 66  
-57  
- 45  
kDa 
B 
b v'- 
x 
Q. 
Q.. 
C) 
..Q 
O,I v 
.< 
D.. 
< 
ll} 
._~ 
.=_ 
E ) 
o 
o 
800 
600 
400. 
200' 
1 2 3 4 
XMEK2 XMEK2 XMpk2 XMEK2 
+ + + 
XMpk2 XMpk2 XMpkl  
4- 
MAPKAP kinase-2 
Fig. 1. XMEK2(E286, E290) phosphorylates and activates XMpk2 in 
vitro. (A) Bacterially produced wild-type GST-XMEK2 or GST- 
XMEK2(E286, E290) proteins (0.5 /Jg) were incubated with MalE- 
XMpk 1 or MalE-XMpk2 ( 1/~g) in 12 ,ul of buffer A containing 10/JM 
ATP and 3 ,uCi [T-32p]ATE After 30 min at 30°C, reaction mixtures 
were heated for 3 min in the presence of SDS, subjected to electropho- 
resis on a 12% polyacrylamide g l and autoradiographed. (B) Recombi- 
nant GST-XMEK2(E286, E290) (0.8/Jg) was incubated for 20 rain at 
30°C with MalE-XMpkl or MalE-XMpk2 (1.5/~g) in 12 ,ul of buffer 
A containing 0.2 mM ATE An aliquot (2 pl) was then incubated with 
GST-MAPKAP kinase-2 in 12/~1 of buffer containing 0.2 mM ATP. 
After 10 min at 22°C and 15 min at 30°C, a 5 ,ul aliquot was assayed 
for MAPKAP kinase-2 activity with the substrate peptide 
KKLNRTLSVA and 0.1 mM [T-32p]ATP (4/JCi) as described [22]. 
X-100, 2.5/11 of 2 M Tris-HC1, pH 8.0, 2,ul of I mg/ml trypsin and 85.5 
,ul water were added, and the suspension incubated for 12 h at 30°C. 
The digest was centrifuged for 5 min at 13,000 x g and the supernatant, 
containing 97% of the 32p radioactivity, chromatographed on a Vydac 
C~8 column (see section 3). In vitro phosphorylated RK was precipi- 
tated with TCA and digested with rypsin in an identical manner except 
that BSA was omitted. 
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Fig. 2. Identification of tryptic phosphopeptides onXMpk2 phosphorylated byXMEK2. (A) 3-'P-Labelled XMpk2 containing 0.23 tool phosphate 
per mol protein, was digested with trypsin and chromatographed on a Vydac C~s column equilibrated in 0.1% (v/v) trifluoroacetic acid (TFA). The 
column was developed with a linear acetonitrile gradient in TFA (broken line) with an increase in acetonitrile concentration of 0.33% per rain and 
fractions of 0.5 ml were collected. The minor and major phosphopeptides referred to in the text are marked 1 and 2, respectively. (B) The major 
phosphopeptide from A (peptide 2) was first sequenced conventionally on an Applied Biosystems 476A Sequencer to identify amino acid residues, 
and then on an Applied Biosystems 470A Sequencer by solid-phase sequencing after coupling the peptide (5000 cpm) covalently to a Sequelon 
arylamine membrane via its carboxyI group [22]. The figure shows 3~,p radioactivity released and amino acid residues (single letter code) identified 
after each cycle of Edman degradation. (C) The minor phosphopeptide-1 from A (1000 cpm) was analysed by solid-phase sequencing as in B. 
3. Results 
3.1. Phosphoo'lation q/the Xenopus RK homologue ( XMpk2 )
in vitro 
A Xenopus cDNA has been identified that encodes a 
MAPKK homologue (XMEK2) more homologous to the up- 
stream activator of S. cerevisiae HOG I (PBS2) than the activa- 
tor of p42/p44 MAPKs (MAPKK- I )  [17]. Activation of 
MAPKK-1 is accompanied by the phosphorylation of Ser-217 
and Ser-221, and changing these residues |o Glu produces a 
MAPK K with a low level of constitutive activity [18]. These two 
serine residues are conserved in all MAPKKs  (although in 
some cases the second Set is substituted for Thr), suggesting 
that all members of this protein kinase subfamily are activated 
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Fig. 3. Activation and phosphorylation of theRK in human KB cells. 
(A) Cell lysates from KB cells (0.3 nag protein) were chromatographed 
on Mono Q as in [2] except that a Pharmacia Smart system was used. 
The column was 5 x 0.16 cm, the gradient was 4 ml and the IYactions 
(0.1 ml) were assayed for RK activity as in [2]. One unit of RK activity 
was that amount which increased the activity of MAPKAP kinase-2 by 
1 U/min. The closed circles show results from arsenite-stimulated cells, 
the open circles results from unstimulated cells, and the broken line the 
NaCI gradient. (B) Mono Q fractions obtained by chromatography f 
an extract from arsenite-stimulated cells [2] were electrophoresed on 
12.5% SDS-polyacrylamide gels and immunoblotted with anti-RK anti- 
body as in [2]. The RK migrated slightly slower than ovalbumin (43 
kDa) corresponding to an apparent molecular mass of 45 kDa. (C) The 
RK was immunoprecipitated from the lysates of 32p-labelled KB cells, 
subjected to electrophoresis as in Band autoradiographed to reveal the 
45 kDa RK protein. Lane 1,RK from unstimulated cells; lane 2, RK 
from cells stimulated for 15 min with 0.5 mM sodium arsenite. No other 
32P-labelled band was immunoprecipitated by the anti-RK antibody. 
by a common mechanism. In order to produce an XMEK2 that 
might be capable of activating the RK, we therefore changed 
Ser-286 and Thr-290 in the activation domain of XMEK2 to 
Glu. GST-XMEK2(E286, E290), but not he wild-type nzyme, 
phosphorylated MalE-XMpk2 (Fig. IA). As a consequence of 
phosphorylation by GST-XMEK2, MalE-XMpk2 was acti- 
vated as shown by its ability to activate recombinant 
GST-MAPKAP kinase-2, the downstream target of XMpk2 
(Fig. 1B). In contrast, recombinant MalE-XMpkl, the other 
known Xenopus MAP kinase homologue, which is more closely 
related to the mammalian p42/p44 MAPKs, was not activated 
by GST-XMEK2(E286, E290) (Fig. I B). 
After incubation with MgATP and GST-XMEK2(E286, 
E290) ['or 16 h as in section 2.4, MalE-XMpk2 was phos- 
phorylated to 0.23 tool phosphate per tool protein and its spe- 
cific activity reached 575 RK U/ml [2]. This phosphorylated 
MalE-XMpk2 was precipitated with TCA and subsequent tryp- 
tic digestion solubilised 97% of the 32p radioactivity. Chroma- 
tography on a C~s column at pH 1.9 revealed two phosphopep- 
tides eluting at 35 rain and 39 min, termed phosphopeptides 1 
and 2, respectively (Fig. 2A). Phosphopeptide 1 accounted for 
7% and phosphopeptide 2 for 51% of the 32p radioactivity 
applied to the column. Phosphopeptide-2 was pure, and its 
sequence HTDEEMTGYVATR corresponded to the tryptic 
peptide containing Thr-181 and Tyr-183 of XMpk2 (Fig. 2B). 
However, a burst of counts occurred only after the ninth cycle 
of Edman degradation, but not after the seventh, indicating 
that Tyr-183 was phosphorylated but that Thr-181 was not. 
This was confirmed by phosphoamino acid analysis which re- 
vealed phosphotyrosine, but no phosphothreonine (data not 
shown). 
3.2. Dephosphoo, lation and inactivation of XMpk2 
RK activation is induced in rat PCI2 cells by incubation with 
sodium arsenite, a compound which mimics the effects of heat 
shock on gene expression and HSP27 phosphorylation [2], and 
the arsenite-activated RK is inactivated by incubation with 
either PP2A or PTP- 1B [2]. In the present work, we found that 
the MalE-XMpk2 which had been activated by GST- 
XMEK2(E286, E290) could be completely inactivated by incu- 
bation with either PP2A or PTP-1B. Inactivation by PP2A, 
which was prevented by the specific inhibitor okadaic acid, was 
accompanied byonly 11% dephosphorylation of MalE-XMpk2 
and resulted in the disappearance of phosphopeptide-1, with no 
effect on phosphopeptide 2 (data not shown). Phosphopeptide- 
1 contained phosphothreonine and phosphotyrosine (data not 
shown), and when subjected to sequence analysis a burst of 3~p 
radioactivity occurred after the seventh and ninth cycles of 
Edman degradation (Fig. 2C), demonstrating that it corre- 
sponds to the doubly phosphorylated derivative of the peptide 
175 187, labelled at both Thr-181 and Tyr-183. Inactivation by 
PTP-1B was accompanied by the total loss of phosphotyrosine 
from MalE-XMpk2 (data not shown). Taken together, the re- 
sults demonstrate that theactivation of MalE-XMpk2 requires 
the phosphorylation f Thr-181 as well as Tyr-183. However 
<15% of the phosphate introduced into XMpk2 under these 
conditions i located at Thr-181. 
3.3. Activation and phosphorylation f the RK in human KB cells 
The RK was inactive in unstimulated KB cells, but became 
active when the cells were incubated with sodium arsenite (Fig. 
3A). As observed previously in rat PCI2 and human HeLa cells 
[2], RK activity was eluted from Mono Q as a sharp peak at 
0.35 M NaC1 mainly in fractions 19 and 20. The anti-RK 
antiserum recognised a 45 kDa protein in immunoblotting ex- 
periments which co-eluted with the RK activity from Mono Q 
(Fig. 3B). The antibody also immunodepleted RK activity from 
the Mono Q fractions (data not shown), and immunoprecipi- 
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Fig. 4. Identification and analysis of ~2p-labeled phosphopeptides obtained by digestion of in vivo phosphorylated RK with trypsin. (A) 32p-Labelled 
RK from arsenitc-treatcd KB cells in Fig. 3C was digested with trypsin and chromatographed on a Vydac C~ column as in Fig. 2A. The open circles 
show the RK phosphopeptides from unstimulated cells, the closed circles phosphopeptides from arsenite-stimulated c lls, and the broken line the 
acelonitrile gradient. (B) Phosphoamino acid analysis of phosphopeptide 1 from A. The phosphopeptide from arsenite-stimulated c lls was incubated 
for 90 rain at l l0°C in 6 M HCI and electrophoresed on thin-layer cellulose at pH 3.5 to resolve orthophosphate (Pi), phosphoserine (pS), 
phosphothreonine (pT) and phosphotyrosine (pY) and autoradiographed. The other ~2p-labelled spots represent partially hydrolysed peptides. 
(C) The sites of phosphorylation i  phosphopeptide-1 from arsenite-stimulated c lls in A were identified by solid-phase sequencing as in Fig. 2B. 
1000 cpm was coupled to the arylamine membrane, and the figure shows the )-~P radioactivity released after each cycle of Edman degradation. 
tated a single 45 kDa 3:p-labelled protein from extracts of KB 
cells which had been incubated with [32P]orthophosphate (Fig. 
3C). The 45 kDa protein was phosphorylated in unstimulated 
cells, but phosphorylation i creased by 90 _+ 40% (+ S.D., three 
experiments) after stimulation for 15 min with 0.5 mM arsenite 
(Fig. 3C). The RK bands from unstimulated and arsenite-stim- 
ulated cells were digested with trypsin and chromatographed 
on a C~s column. The RK from unstimulated cells showed four 
tryptic phosphopeptides, and phosphopeptide 1 during at 
35 min was increased dramatically after stimulation 
with arsenite (Fig. 4A). Phosphopeptide-1 contained phos- 
phothreonine and phosphotyrosine (Fig. 4B), co-eluted 
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with the diphosphorylated derivative of the peptide 175-187 
from MalE-XMpk2 phosphorylated in vitro by GST-XMEK2 
(Fig. 2A), and was phosphorylated at the seventh and ninth 
residues (Fig. 4C) as expected. The sequence of the peptide 
175 187 from MalE-XMpk2 [2] only differs from human RK 
[8] in having Glu at residue 178 instead of Asp, which does not 
affect its elution from the Cl8 column significantly. The minor 
phosphopeptide-2 from arsenite-treated cells, eluting at 38/39 
rain largely contained phosphotyrosine (data not shown) and 
presumably represents monophosphorylated d rivatives of the 
peptide 175 187 (mainly labelled at Tyr-183 only, see Fig. 2). 
Phosphopeptides 3 and 4 eluting at 54 and 59 min were unaf- 
fected by stimulating cells with arsenite (Fig. 4A) and contained 
phosphoserine only (data not shown). 
4. Discussion 
Here, we have established that the RK, like p42/p44 MAPKs, 
is only active if phosphorylated at both the Thr and the Tyr 
residue in the Thr-Xaa-Tyr motif (Thr-180 and Tyr-182 of 
human RK; Thr-181 and Tyr-183 of XMpk2), and inactivated 
when phosphate is removed from either esidue. Since Thr- 180 
and Tyr-182 are both phosphorylated to a similar extent after 
stimulation of human KB cells for 15 min with arsenite, and no 
other residues are phosphorylated in response to this stimulus 
(Fig. 4C), the phosphorylation f these residues clearly under- 
lies the stress-induced activation of RK. The reason why activa- 
tion of RK and p42/p44 MAPKs involves uch a dual Thr/Tyr 
phosphorylation is still unclear, although one possibility is that 
it allows dephosphorylation and inactivation to be controlled 
in a complex and sophisticated manner by three types of protein 
phosphatase (see section 1 and [11]). 
MAPKK- 1 phosphorylates Tyr- 185 of p42 MAPK preferen- 
tially [19], and the present work shows that GST- 
XMEK2(E286, E290) also phosphorylates the Xenopus RK 
homologue XMpk2 much more rapidly at Tyr-183 than at 
Thr-181 in vitro. Indeed, we cannot be certain that GST- 
XMEK2 phosphorylates Thr-181 at all, because phosphoryla- 
tion of Tyr-183 by XMEK2 may then permit MalE-XMpk2 to 
slowly phosphorylate itself at Thr-181. However, GST- 
XMEK2(E286, E290) phosphorylates MalE-XMpk2 poorly 
because, even after incubation for 16 h at a molar ratio GST- 
XMEK2/MalE-XMpk2 of 1:5, Tyr-183 of XMPK2 was 
phosphorylated to only 0.20 tool/tool, while Thr-181 was 
phosphorylated to 0.03 mol/mol. After incubation for much 
shorter times (0.5 2 h) the phosphorylation f Thr-181 was far 
lower, but phosphorylation f Tyr-183 was only reduced to a 
small extent. 
While our work was in progress, the sequence of a mammal- 
ian MAPKK homologue was reported, termed SEK1 [20] or 
MKK4 [21], whose catalytic domain is >90% identical to 
XMEK2. MKK4 was reported to phosphorylate and activate 
the RK in vitro (termed p38 MAP kinase by these investigators 
[21]) and SEKl to phosphorylate another stress and cytokine- 
activated MAP kinase homologue, termed c-Jun kinase (JNK) 
or stress-activated protein kinase (SAPK) [20]. JNK/SAPK was 
reported to be phosphorylated onTyr and not Thr in vitro by 
SEKI recovered from anisomycin-treated c lls, but the effect 
of PP2A and PTPases on JNK/SAPK which had been activated 
by MKK4/SEK1 was not reported. Further work is needed to 
find out whether MKK4/SEKI/XMEK2, or other enzymes, are 
responsible for activating the RK and/or JNK/SAPK in vivo. 
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